Sudhir S. Kushwaha, M.D.

  1. Cardiologist
  1. Taner T, Biggins SW, Cummins N, Daly RC, Dietz AB, Emamaullee J, Gandhi MJ, Heimbach JK, Patel JK, Pereira NL, Rosenbaum A, Sanchez-Fueyo A, Shingina A, Stegall MD, Villavicencio Theoduloz MA, Wald JW, Kushwaha SS, Consensus Conference participants. Summary of a Consensus Conference on the Management of Highly Sensitized Multiorgan Transplant Candidates. Mayo Clin Proc. 2025 Apr; 100 (4):700-711 Epub 2025 Mar 08
    View PubMed
  2. Inglis SS, Schettle SD, Villavicencio MA, Spencer PJ, Stulak JM, Tang PC, Kushwaha SS, Behfar A, Rosenbaum AN. Assessment of Left-Sided Hemodynamics With Exercise in Patients With Continuous Flow Left Ventricular Assist Device Support. Artif Organs. 2025 Mar 13 [Epub ahead of print]
    View PubMed
  3. Alnsasra H, Perue RK, Khalil F, Regev O, Kushwaha SS, Briasoulis A, Asleh R. Reversibility of precapillary pulmonary hypertension and outcomes after heart transplantation bridged with left ventricular assist devices: Insight from the United Network for Organ Sharing. J Thorac Cardiovasc Surg. 2025 Jan; 169 (1):124-133.e4 Epub 2024 Mar 05
    View PubMed
  4. Lyle MA, Farina JMM, Wiedmeier-Nutor E, Lindpere V, Klanderman M, Nativi-Nicolau JN, Leoni Moreno JC, Goswami RM, Yip DS, Patel PC, Sher T, Rosenbaum AN, AbouEzzeddine OF, Boilson BA, Kushwaha SS, Clavell AL, Steidley DE, Hardaway BW, Scott RL, LeMond LM, Fonseca R, Gertz MA, Dispenzieri A, Grogan M, Rosenthal JL. Amyloidosis and Heart Transplantation in a New Era. Clin Transplant. 2025 Jan; 39(1):e70070.
    View PubMed
  5. Inglis SS, Abbas M, Asleh R, Garmany A, Smith BH, Kushwaha S, Pereira N, Clavell AL, Villavicencio MA, Spencer PJ, Daly RC, Behfar A, Rosenbaum AN. Incidence and risk factors for rejection after conversion from calcineurin inhibitor to sirolimus-based immunosuppression in orthotopic heart transplant recipients. J Heart Lung Transplant. 2024 Dec 30 [Epub ahead of print]
    View PubMed
  6. Alnsasra H, Asleh R, Khalil F, Akiki E, Briasoulis A, Dean PG, Bentall AJ, Kushwaha SS. Treatment With mTOR Inhibitors as Primary Immunosuppression After Combined Heart and Kidney Transplantation. J Card Fail. 2024 Dec 7 Epub 2024 Dec 07
    View PubMed
  7. Stephens EH, Dearani JA, Griffeth EM, Altarabsheh SEI, Ameduri RK, Johnson JN, Burchill LJ, Miranda WR, Connolly HM, Kushwaha SS, Pereira NL, Villavicencio MA, Daly RC. Adult Congenital Heart Disease Transplantation: Does Univentricle Physiology Impact Early Mortality? Ann Thorac Surg. 2024 Nov; 118 (5):1088-1096 Epub 2024 June 29
    View PubMed
  8. Anand S, Alnsasra H, LeMond LM, Shrivastava S, Asleh R, Rosenbaum A, Kobrossi S, Mohananey A, Murphy K, Smith BH, Kushwaha S, Steidley DE, Clavell A, Young P, Pereira NL. Cardiac magnetic resonance imaging in heart transplant recipients with biopsy-negative graft dysfunction. ESC Heart Fail. 2024 Jun; 11 (3):1594-1601 Epub 2024 Feb 20
    View PubMed
  9. Inglis SS, Asleh R, Iyer VN, Schettle SD, Spencer PJ, Villavicencio MA, Rodeheffer RJ, Kushwaha SS, Behfar A, Rosenbaum AN. Inhibition of angiogenesis in the management of refractory gastrointestinal bleeding in patients with LVAD support. Artif Organs. 2024 Jun; 48 (6):646-654 Epub 2023 Dec 22
    View PubMed
  10. Kobashigawa J, VanWagner LB, Hall S, Emamaullee J, Entwistle JW, Ganger D, Gebel H, Jeevanandam V, Kaldas F, Kilic A, Kittleson M, Kushwaha S, Kwong A, Lui GK, Motayagheni N, Patel J, Patel N, Pereira N, Potter L, Sani M, Schiano TD, Shingina A, Consensus Conference participants. Summary of a consensus conference on heart-liver transplantation. Am J Transplant. 2024 Mar; 24 (3):380-390 Epub 2023 Dec 09
    View PubMed
  11. Bailey ME, Durst L, Cajigas HR, Kane GC, Krowka MJ, Kushwaha SS, McCully RB, Murphy JG, Reddy YN, Frantz RP, DuBrock HM. Using PAH-SYMPACT to assess quality of life in patients with pulmonary hypertension associated with chronic lung disease. Pulm Circ. 2024 Jan; 14 (1):e12343 Epub 2024 Feb 10
    View PubMed
  12. Asleh R, Alnsasra H, Villavicencio MA, Daly RC, Kushwaha SS. Cardiac Transplantation: Physiology and Natural History of the Transplanted Heart. Compr Physiol. 2023 Jun 26; 13 (3):4719-4765 Epub 2023 June 26
    View PubMed
  13. Inglis SS, Villavicencio MT, Spencer PJ, Schettle SD, Stulak JM, Clavell AL, Kushwaha SS, Behfar A, Rosenbaum AN. Interventricular-Septal Output While Supported on Left Ventricular Assist Device Therapy. ASAIO J. 2023 May 1; 69 (5):424-428 Epub 2022 Nov 07
    View PubMed
  14. Rosenbaum AN, Rossman TL, Reddy YN, Villavicencio MA, Stulak JM, Spencer PJ, Kushwaha SS, Behfar A. Pulsatile Pressure Delivery of Continuous-Flow Left Ventricular Assist Devices Is Markedly Reduced Relative to Heart Failure Patients. ASAIO J. 2023 May 1; 69 (5):445-450 Epub 2022 Nov 22
    View PubMed
  15. Griffeth EM, Burchill LJ, Dearani JA, Oberoi M, Abdelrehim AA, O'Leary PW, Edwards BS, Kushwaha SS, Daly RC, Cetta F, Johnson JN, Ameduri RK, Stephens EH. Optimizing Referral Timing of Patients With Fontan Circulatory Failure for Heart Transplant. Transplant Proc. 2023 Mar; 55 (2):417-425 Epub 2023 Mar 01
    View PubMed
  16. Park HW, Ozcan I, Toya T, Ahmad A, Kanaji Y, Kushwaha SS, Lerman LO, Lerman A. Invasive aortic pulse pressure is linked to cardiac allograft vasculopathy after heart transplantation. Int J Cardiol. 2023 Jan 1; 370:167-174 Epub 2022 Oct 29
    View PubMed
  17. Ozcan I, Toya T, Cohen-Shelly M, Park HW, Ahmad A, Ozcan A, Noseworthy PA, Kapa S, Lerman LO, Attia ZI, Kushwaha SS, Friedman PA, Lerman A. Artificial intelligence-derived cardiac ageing is associated with cardiac events post-heart transplantation. Eur Heart J Digit Health. 2022 Dec; 3 (4):516-524 Epub 2022 Sept 16
    View PubMed
  18. DuBrock HM, Reddy YN, Durst LA, Schroeder DR, Park G, Cajigas HR, Kane GC, Kushwaha SS, McCully RB, Murphy JG, Anand V, Krowka MJ, Frantz RP. The feasibility and value of assessing patient-reported outcomes in pulmonary arterial hypertension. Pulm Circ. 2022 Oct; 12 (4):e12143 Epub 2022 Oct 01
    View PubMed
  19. Ozcan I, Toya T, Corban MT, Ahmad A, Loeffler D, Morse D, Lerman LO, Kushwaha SS, Lerman A. Circulating progenitor cells are associated with plaque progression and long-term outcomes in heart transplant patients. Cardiovasc Res. 2022 Jun 22; 118 (7):1703-1712
    View PubMed
  20. Rosenbaum AN, Geske JB, Stulak JM, Kushwaha SS, Clavell AL, Behfar A. Left Ventricular Hemodynamics and Relationship With Myocardial Recovery and Optimization in Patients Supported on CF-LVAD Therapy. J Card Fail. 2022 May; 28 (5):799-806 Epub 2021 Dec 17
    View PubMed
  21. Asleh R, Briasoulis A, Doulamis I, Alnsasra H, Tzani A, Alvarez P, Kuno T, Kampaktsis P, Kushwaha S. Outcomes after heart transplantation in patients with cardiac sarcoidosis. ESC Heart Fail. 2022 Apr; 9 (2):1167-1174 Epub 2022 Jan 15
    View PubMed
  22. Cain MT, Joyce D, Lahr BD, Day CN, Sandhu GS, Kushwaha S, Joyce LD. Do Right Heart Hemodynamic Improvements Persist After Pulmonary Thromboendarterectomy? Semin Thorac Cardiovasc Surg. 2022 Spring; 34 (1):80-89 Epub 2021 Mar 07
    View PubMed
  23. Asleh R, Vucicevic D, Petterson TM, Kremers WK, Pereira NL, Daly RC, Edwards BS, Steidley DE, Scott RL, Kushwaha SS. Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center Study. J Clin Med. 2022 Jan 10; 11 (2)
    View PubMed
  24. Asleh R, Alnsasra H, Habermann TM, Briasoulis A, Kushwaha SS. Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation. Front Cardiovasc Med. 2022; 9:787975 Epub 2022 Feb 23
    View PubMed
  25. Rosenbaum AN, Antaki JF, Behfar A, Villavicencio MA, Stulak J, Kushwaha SS. Physiology of Continuous-Flow Left Ventricular Assist Device Therapy. Compr Physiol. 2021 Dec 29; 12 (1):2731-2767
    View PubMed
  26. Ozcan I, Toya T, Corban MT, Ahmad A, Lerman LO, Kushwaha SS, Lerman A. Peripheral microvascular dysfunction is associated with plaque progression and adverse long-term outcomes in heart transplant patients. ESC Heart Fail. 2021 Dec; 8 (6):5266-5274 Epub 2021 Sept 12
    View PubMed
  27. Bubik RJ, Dierkhising RA, Mara KC, Daly RC, Kushwaha SS, Clavell AL, Bernard SA. Malignancy among adult heart transplant recipients following patient-tailored dosing of anti-thymocyte globulin: a retrospective, nested case-control study of individualized dosing. Transpl Int. 2021 Nov; 34 (11):2175-2183 Epub 2021 Sept 23
    View PubMed
  28. Alnsasra H, Asleh R, Kumar N, Lopez C, Toya T, Kremers WK, Edwards B, Daly RC, Kushwaha SS. Incidence, Risk Factors, and Outcomes of Stroke Following Cardiac Transplantation. Stroke. 2021 Nov; 52 (11):e720-e724 Epub 2021 Sept 02
    View PubMed
  29. Yetmar ZA, Lahr B, Brumble L, Gea Banacloche J, Steidley DE, Kushwaha S, Beam E. Epidemiology, risk factors, and association of antifungal prophylaxis on early invasive fungal infection in heart transplant recipients. Transpl Infect Dis. 2021 Oct; 23 (5):e13714 Epub 2021 Sept 09
    View PubMed
  30. King RL, Khurana A, Mwangi R, Fama A, Ristow KM, Maurer MJ, Macon WR, Ansell SM, Bennani NN, Kudva YC, Walker RC, Watt KD, Schwab TR, Kushwaha SS, Cerhan JR, Habermann TM. Clinicopathologic Characteristics, Treatment, and Outcomes of Post-transplant Lymphoproliferative Disorders: A Single-institution Experience Using 2017 WHO Diagnostic Criteria. Hemasphere. 2021 Oct; 5 (10):e640 Epub 2021 Sept 06
    View PubMed
  31. Shrivastava S, Kruisselbrink TM, Mohananey A, Thomas BC, Kushwaha SS, Pereira NL. Rare TBX4 Variant Causing Pulmonary Arterial Hypertension With Small Patella Syndrome in an Adult Man. JACC Case Rep. 2021 Sep 15; 3 (12):1447-1452 Epub 2021 Sept 15
    View PubMed
  32. Asleh R, Briasoulis A, Smith B, Lopez C, Alnsasra H, Pereira NL, Edwards BS, Clavell AL, Stulak JM, Locker C, Kremers WK, Daly RC, Lerman A, Kushwaha SS. Association of Aspirin Treatment With Cardiac Allograft Vasculopathy Progression and Adverse Outcomes After Heart Transplantation. J Card Fail. 2021 May; 27 (5):542-551
    View PubMed
  33. Daly RC, Rosenbaum AN, Dearani JA, Clavell AL, Pereira NL, Boilson BA, Frantz RP, Behfar A, Dunlay SM, Rodeheffer RJ, Schirger JA, Taner T, Gandhi MJ, Heimbach JK, Rosen CB, Edwards BS, Kushwaha SS. Heart-After-Liver Transplantation Attenuates Rejection of Cardiac Allografts in Sensitized Patients. J Am Coll Cardiol. 2021 Mar 16; 77 (10):1331-1340
    View PubMed
  34. Asleh R, Alnsasra H, Lerman A, Briasoulis A, Pereira NL, Edwards BS, Toya T, Stulak JM, Clavell AL, Daly RC, Kushwaha SS. Effects of mTOR inhibitor-related proteinuria on progression of cardiac allograft vasculopathy and outcomes among heart transplant recipients. Am J Transplant. 2021 Feb; 21 (2):626-635 Epub 2020 July 21
    View PubMed
  35. Alnsasra H, Asleh R, Oh JK, Maleszewski JJ, Lerman A, Toya T, Chandrasekaran K, Bois MC, Kushwaha SS. Impact of Sirolimus as a Primary Immunosuppressant on Myocardial Fibrosis and Diastolic Function Following Heart Transplantation. J Am Heart Assoc. 2021 Jan 5; 10 (1):e018186 Epub 2020 Dec 16
    View PubMed
  36. Schaefer JJ, Sajgalik P, Kushwaha SS, Olson LJ, Stulak JM, Johnson BD, Schirger JA. Left ventricle assist device pulsatility index at the time of implantation is associated with follow-up pulmonary hemodynamics. Int J Artif Organs. 2020 Jul; 43 (7):452-460 Epub 2020 Jan 27
    View PubMed
  37. Asleh R, Albitar HAH, Schettle SD, Kushwaha SS, Pereira NL, Behfar A, Stulak JM, Rodeheffer RJ, Iyer VN. Intravenous bevacizumab as a novel treatment for refractory left ventricular assist device-related gastrointestinal bleeding. J Heart Lung Transplant 2020 May; 39 (5):492-495 Epub 2020 Feb 24
    View PubMed
  38. Steadman JA, Stulak JM, Clavell AL, Kushwaha SS, Edwards BS, Pereira NL, Dunlay SM, Schirger JA, Frantz RP, Smith BH, Dean PG, Daly RC. Combined Heart-Kidney Transplantation: Vasoplegia is Associated with Poorer Post-Kidney Transplant Outcomes. J Heart Lung Transplant. 2020 Apr; 39 (4S):S267 Epub 2020 Mar 30
    View PubMed
  39. Sajgalik P, Kim C, Wheatley-Guy C, Clavell AL, Kushwaha SS, Stulak JM, Schettle SD, Cierzan BS, Schirger JA, Johnson BD. Pilot Studies towards Optimizing Quality of Life and Outcomes in Patients Post Left Ventricular Assist Device Implantation. J Heart Lung Transplant. 2020 Apr; 39 (4S):S331 Epub 2020 Mar 30
    View PubMed
  40. Asleh R, Briasoulis A, Smith B, Lopez C, Lerman A, Pereira NL, Daly RC, Kremers WK, Clavell AL, Stulak JM, Kushwaha SS. Effects of Aspirin on Progression of Cardiac Allograft Vasculopathy and Outcomes after Heart Transplantation. J Heart Lung Transplant. 2020 Apr; 39 (4S):S76 Epub 2020 Mar 30
    View PubMed
  41. Cross TJ, Sajgalik P, Fabian V, Matera L, Kushwaha SS, Maltais S, Stulak JM, Schirger JA, Johnson BD. Non-invasive assessment of arterial pulsatility in patients with continuous-flow left ventricular assist devices. Int J Artif Organs. 2020 Feb; 43 (2):99-108 Epub 2019 Aug 14
    View PubMed
  42. Asleh R, Alnsasra H, Daly RC, Schettle SD, Briasoulis A, Taher R, Dunlay SM, Stulak JM, Behfar A, Pereira NL, Frantz RP, Edwards BS, Clavell AL, Kushwaha SS. Predictors and Clinical Outcomes of Vasoplegia in Patients Bridged to Heart Transplantation With Continuous-Flow Left Ventricular Assist Devices. J Am Heart Assoc. 2019 Nov 19; 8 (22):e013108 Epub 2019 Nov 08
    View PubMed
  43. Alnsasra H, Asleh R, Schettle SD, Pereira NL, Frantz RP, Edwards BS, Clavell AL, Maltais S, Daly RC, Stulak JM, Rosenbaum AN, Behfar A, Kushwaha SS. Diastolic Pulmonary Gradient as a Predictor of Right Ventricular Failure After Left Ventricular Assist Device Implantation. J Am Heart Assoc. 2019 Aug 20; 8(16):e012073. Epub 2019 Aug 14.
    View PubMed
  44. Asleh R, Schettle SS, Khan FW, Kushwaha SS. Left ventricular assist devices as destination therapy in stage D heart failure. J Geriatr Cardiol. 2019 Aug; 16 (8):592-600
    View PubMed
  45. Asleh R, Clavell AL, Pereira NL, Smith B, Briasoulis A, Alnsasra H, Kremers WK, Habermann TM, Otley CC, Li X, Edwards BS, Stulak JM, Daly RC, Kushwaha SS. Incidence of Malignancies in Patients Treated With Sirolimus Following Heart Transplantation. J Am Coll Cardiol. 2019 Jun 4; 73 (21):2676-2688
    View PubMed
  46. Asleh R, Schettle S, Briasoulis A, Killian JM, Stulak JM, Pereira NL, Kushwaha SS, Maltais S, Dunlay SM. Predictors and Outcomes of Renal Replacement Therapy After Left Ventricular Assist Device Implantation. Mayo Clin Proc. 2019 Jun; 94 (6):1003-1014
    View PubMed
  47. Rosenbaum AN, Frantz RP, Kushwaha SS, Stulak JM, Maltais S, Behfar A. Novel Left Heart Catheterization Ramp Protocol to Guide Hemodynamic Optimization in Patients Supported With Left Ventricular Assist Device Therapy. J Am Heart Assoc. 2019 Feb 19; 8 (4):e010232
    View PubMed
  48. Sajgalik P, Kim CH, Stulak JM, Kushwaha SS, Maltais S, Joyce DL, Joyce LD, Johnson BD, Schirger JA. Pulmonary function assessment post-left ventricular assist device implantation. ESC Heart Fail. 2019 Feb; 6 (1):53-61 Epub 2018 Oct 12
    View PubMed
  49. Sajgalik P, Kremen V, Fabian V, Maltais S, Stulak JM, Kushwaha SS, Joyce LD, Schirger JA, Johnson BD. Noninvasive Blood Pressure Monitor Designed for Patients With Heart Failure Supported with Continuous-Flow Left Ventricular Assist Devices. ASAIO J. 2019 Feb; 65 (2):127-133
    View PubMed
  50. Asleh R, Briasoulis A, Pereira NL, Boilson BA, Edwards BS, Adigun R, Maltais S, Daly RC, Lerman A, Kushwaha SS. Timing of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor initiation and allograft vasculopathy progression and outcomes in heart transplant recipients. ESC Heart Fail. 2018 Dec; 5 (6):1118-1129 Epub 2018 July 17
    View PubMed
  51. Rosenbaum AN, AbouEzzeddine OF, Grogan M, Dispenzieri A, Kushwaha S, Clavell A, Daly RC, Edwards BS. Outcomes After Cardiac Transplant for Wild Type Transthyretin Amyloidosis. Transplantation. 2018 Nov; 102 (11):1909-1913
    View PubMed
  52. Schettle S, Schloglhofer T, Zimpfer D, Schima H, Kaufmann F, Salimbangon A, Wolforth J, Schroeder S, Hards R, Ritchie B, Staley L, Pereira N, Kushwaha S, Maltais S, Stulak J. International Analysis of LVAD Point-of-Care Versus Plasma INR: A Multicenter Study. ASAIO J. 2018 Nov/Dec; 64 (6):e161-e165
    View PubMed
  53. Asleh R, Briasoulis A, Pereira NL, Edwards BS, Frantz RP, Daly RC, Lerman A, Kushwaha SS. Hypercholesterolemia after conversion to sirolimus as primary immunosuppression and cardiac allograft vasculopathy in heart transplant recipients. J Heart Lung Transplant. 2018 Nov; 37 (11):1372-1380 Epub 2018 Aug 30
    View PubMed
  54. Asleh R, Snipelisky D, Hathcock M, Kremers W, Liu D, Batzler A, Jenkins G, Kushwaha S, Pereira NL. Genomewide association study reveals novel genetic loci associated with change in renal function in heart transplant recipients. Clin Transplant. 2018 Oct; 32 (10):e13395 Epub 2018 Oct 02
    View PubMed
  55. Asleh R, Prasad M, Briasoulis A, Nardi V, Adigun R, Edwards BS, Pereira NL, Daly RC, Lerman A, Kushwaha SS. Uric acid is an independent predictor of cardiac allograft vasculopathy after heart transplantation. J Heart Lung Transplant. 2018 Sep; 37(9):1083-1092. Epub 2018 May 01.
    View PubMed
  56. Grupper A, AbouEzzeddine OF, Maleszewski JJ, Grupper A, Geske JR, Kremers WK, Kushwaha SS, Pereira NL. Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipients. Clin Transplant. 2018 Sep; 32 (9):e13349 Epub 2018 July 26
    View PubMed
  57. Anwer LA, Tchantchaleishvili V, Poddi S, Daly RC, Joyce LD, Kushwaha SS, Topilsky Y, Stulak JM, Maltais S. Atrial Fibrillation Should Guide Prophylactic Tricuspid Procedures During Left Ventricular Assist Device Implantation. ASAIO J. 2018 Sep/Oct; 64 (5):586-593
    View PubMed
  58. Joyce DL, Lahr BD, Joyce LD, Kushwaha SS, Daly RC. Prediction Model for Wait Times in Cardiac Transplantation. ASAIO J. 2018 Sep/Oct; 64 (5):680-685
    View PubMed
  59. Asleh R, Hasin T, Briasoulis A, Schettle SD, Borlaug BA, Behfar A, Pereira NL, Edwards BS, Clavell AL, Joyce LD, Maltais S, Stulak JM, Kushwaha SS. Hemodynamic Assessment of Patients With and Without Heart Failure Symptoms Supported by a Continuous-Flow Left Ventricular Assist Device. Mayo Clin Proc. 2018 Jul; 93 (7):895-903 Epub 2018 June 19
    View PubMed
  60. Nestorovic E, Schmitto JD, Kushwaha SS, Putnik S, Terzic D, Milic N, Mikic A, Markovic D, Trifunovic D, Ristic A, Ristic M. Successful establishment of a left ventricular assist device program in an emerging country: one year experience. J Thorac Dis. 2018 Jun; 10 (Suppl 15):S1743-S1750
    View PubMed
  61. Grupper A, Gewirtz H, Kushwaha S. Reinnervation post-heart transplantation. Eur Heart J. 2018 May 21; 39 (20):1799-1806
    View PubMed
  62. Joyce DL, Redfield MM, Kushwaha SS, Behfar A, Borlaug BA, Daly RC, Sandhu GS, Joyce LD. Pulmonary Pressure Assessment with the Total Artificial Heart. ASAIO J. 2018 May/Jun; 64 (3):e34-e36
    View PubMed
  63. Asleh R, Sheikh-Ahmad M, Briasoulis A, Kushwaha SS. The influence of anti-hyperglycemic drug therapy on cardiovascular and heart failure outcomes in patients with type 2 diabetes mellitus. Heart Fail Rev. 2018 May; 23 (3):445-459
    View PubMed
  64. Asleh R, Briasoulis A, Kremers WK, Adigun R, Boilson BA, Pereira NL, Edwards BS, Clavell AL, Schirger JA, Rodeheffer RJ, Frantz RP, Joyce LD, Maltais S, Stulak JM, Daly RC, Tilford J, Choi WG, Lerman A, Kushwaha SS. Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant Recipients. J Am Coll Cardiol. 2018 Feb 13; 71 (6):636-650
    View PubMed
  65. Asleh R, Briasoulis A, Berinstein EM, Wiener JB, Palla M, Kushwaha SS, Levy AP. Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation. Pharmgenomics Pers Med. 2018; 11:71-82 Epub 2018 Apr 23
    View PubMed
  66. Rosenbaum AN, Dunlay SM, Pereira NL, Allison TG, Maltais S, Stulak JM, Joyce LD, Kushwaha SS. Determinants of Improvement in Cardiopulmonary Exercise Testing After Left Ventricular Assist Device Implantation. ASAIO J. 2018 Sep/Oct; 64(5):610-615.
    View PubMed
  67. Akintoye E, Briasoulis A, Egbe A, Dunlay SM, Kushwaha S, Levine D, Afonso L, Mozaffarian D, Weinberger J. National Trends in Admission and In-Hospital Mortality of Patients With Heart Failure in the United States (2001-2014). J Am Heart Assoc. 2017 Nov 29; 6 (12)
    View PubMed
  68. Asleh R, Briasoulis A, Schettle SD, Tchantchaleishvili V, Pereira NL, Edwards BS, Clavell AL, Maltais S, Joyce DL, Joyce LD, Daly RC, Kushwaha SS, Stulak JM. Impact of Diabetes Mellitus on Outcomes in Patients Supported With Left Ventricular Assist Devices: A Single Institutional 9-Year Experience. Circ Heart Fail. 2017 Nov; 10 (11)
    View PubMed
  69. Wong KL, Taner T, Smith BH, Kushwaha SS, Edwards BS, Gandhi MJ, Kremers WK, Daly RC, Pereira NL. Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation. Circulation 2017 Oct 3; 136 (14):1350-1352
    View PubMed
  70. Akintoye E, Briasoulis A, Egbe A, Adegbala O, Sheikh M, Singh M, Alliu S, Ahmed A, Asleh R, Kushwaha S, Levine D. Regional Variation in Mortality, Length of Stay, Cost, and Discharge Disposition Among Patients Admitted for Heart Failure in the United States. Am J Cardiol. 2017 Sep 01; 120 (5):817-824 Epub 2017 June 15
    View PubMed
  71. Grupper A, Grupper A, Daly RC, Pereira NL, Hathcock MA, Kremers WK, Cosio FG, Edwards BS, Kushwaha SS. Renal Allograft Outcome After Simultaneous Heart and Kidney Transplantation. Am J Cardiol. 2017 Aug 1; 120 (3):494-499 Epub 2017 May 11
    View PubMed
  72. Hasin T, Grupper A, Dillon JJ, Maleszewski JJ, Li Z, Topilsky Y, Frantz RP, Edwards BS, Pereira NL, Maltais S, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May Not Persist to One Year. ASAIO J. 2017 Jul/Aug; 63 (4):401-407
    View PubMed
  73. Bellavia D, Iacovoni A, Scardulla C, Moja L, Pilato M, Kushwaha SS, Senni M, Clemenza F, Agnese V, Falletta C, Romano G, Maalouf J, Dandel M. Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail. 2017 Jul; 19 (7):926-946 Epub 2017 Mar 31
    View PubMed
  74. asleh, schettle, kushwaha. Diabetes JHLT.2017;
  75. Grupper A, Grupper A, Daly RC, Pereira NL, Hathcock MA, Kremers WK, Cosio FG, Edwards BS, Kushwaha SS. Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation. J Heart Lung Transplant. 2017 Mar; 36 (3):297-304 Epub 2016 Aug 18
    View PubMed
  76. Simha V, Qin S, Shah P, Smith BH, Kremers WK, Kushwaha S, Wang L, Pereira NL. Sirolimus Therapy Is Associated with Elevation in Circulating PCSK9 Levels in Cardiac Transplant Patients. J Cardiovasc Transl Res. 2017 Feb; 10 (1):9-15 Epub 2016 Dec 27
    View PubMed
  77. Nestorovic EM, Grupper A, Joyce LD, Milic NM, Stulak JM, Edwards BS, Pereira NL, Daly RC, Kushwaha SS. Effect of Pretransplant Continuous-Flow Left Ventricular Assist Devices on Cellular and Antibody-Mediated Rejection and Subsequent Allograft Outcomes. Am J Cardiol. 2017 Feb 1; 119 (3):452-456 Epub 2016 Nov 01
    View PubMed
  78. Park KH, Sun T, Liu Z, Yang SW, Lennon RJ, Lerman LO, Kushwaha SS, Lerman A. Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation. J Heart Lung Transplant. 2017 Feb; 36 (2):185-192 Epub 2016 June 07
    View PubMed
  79. Acheampong B, Johnson JN, Stulak JM, Dearani JA, Kushwaha SS, Daly RC, Haile DT, Schears GJ. Postcardiotomy ECMO Support after High-risk Operations in Adult Congenital Heart Disease. Congenit Heart Dis. 2016 Dec; 11: (6)751-755.
    View PubMed
  80. Fine NM, Kushwaha SS. Recent Advances in Mammalian Target of Rapamycin Inhibitor Use in Heart and Lung Transplantation. Transplantation. 2016 Dec; 100 (12):2558-2568
    View PubMed
  81. Wong TW, Gandhi MJ, Daly RC, Kushwaha SS, Pereira NL, Rosen CB, Stegall MD, Heimbach JK, Taner T. Liver Allograft Provides Immunoprotection for the Cardiac Allograft in Combined Heart-Liver Transplantation. Am J Transplant. 2016 Dec; 16 (12):3522-3531 Epub 2016 June 24
    View PubMed
  82. Grupper A, Nativi-Nicolau J, Maleszewski JJ, Geske JR, Kremers WK, Edwards BS, Kushwaha SS, Pereira NL. Circulating Galectin-3 Levels Are Persistently Elevated After Heart Transplantation and Are Associated With Renal Dysfunction. JACC Heart Fail. 2016 Nov; 4 (11):847-856 Epub 2016 Sept 07
    View PubMed
  83. Maltais S, Davis ME, Haglund NA, Perrault L, Kushwaha SS, Stulak JM, Boyle EM. Active Clearance of Chest Tubes Reduces Re-Exploration for Bleeding After Ventricular Assist Device Implantation. ASAIO J. 2016 Nov/Dec; 62 (6):704-709
    View PubMed
  84. Grupper A, Nestorovic EM, Daly RC, Milic NM, Joyce LD, Stulak JM, Joyce DL, Edwards BS, Pereira NL, Kushwaha SS. Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience. Transplant Direct. 2016 Oct; 2 (10):e106 Epub 2016 Sept 13
    View PubMed
  85. Sileshi B, O'Hara BK, Davis ME, Haglund NA, Meng X, Deegan R, Stulak JM, Kushwaha SS, Shaw A, Maltais S. Outcomes of Patients Implanted Using a Left Thoracotomy Technique for a Miniaturized Centrifugal Continuous-Flow Pump. ASAIO J. 2016 Sep-Oct; 62 (5):539-44
    View PubMed
  86. Larsen CM, McCully RB, Murphy JG, Kushwaha SS, Frantz RP, Kane GC. Usefulness of High-Density Lipoprotein Cholesterol to Predict Survival in Pulmonary Arterial Hypertension. Am J Cardiol. 2016 Jul 15; 118: (2)292-7.
    View PubMed
  87. Danish TF, Davis ME, Xu M, Djunaidi M, Danter MR, Kushwaha SS, Stulak JM, Haglund NA, Maltais S. Can an Alternative Outflow Strategy be Utilized for High-Risk Bridged Patients with Previous Cardiac Surgery? ASAIO J. 2016 Jul-Aug; 62 (4):390-6
    View PubMed
  88. Sajgalik P, Grupper A, Edwards BS, Kushwaha SS, Stulak JM, Joyce DL, Joyce LD, Daly RC, Kara T, Schirger JA. Current Status of Left Ventricular Assist Device Therapy. Mayo Clin Proc. 2016 Jul; 91 (7):927-40
    View PubMed
  89. Grogan M, Gertz M, McCurdy A, Roeker L, Kyle R, Kushwaha S, Daly R, Dearani J, Rodeheffer R, Frantz R, Lacy M, Hayman S, McGregor C, Edwards B, Dispenzieri A. Long term outcomes of cardiac transplant for immunoglobulin light chain amyloidosis: The Mayo Clinic experience. World J Transplant. 2016 Jun 24; 6(2):380-8.
    View PubMed
  90. Grupper A, Zhao YM, Sajgalik P, Joyce LD, Park SJ, Pereira NL, Stulak JM, Burnett JC Jr, Edwards BS, Daly RC, Kushwaha SS, Schirger JA. Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation. Am J Cardiol. 2016 Jun 1; 117 (11):1765-70 Epub 2016 Mar 18
    View PubMed
  91. Fine NM, Park SJ, Stulak JM, Topilsky Y, Daly RC, Joyce LD, Pereira NL, Schirger JA, Edwards BS, Lin G, Kushwaha SS. Proximal thoracic aorta dimensions after continuous-flow left ventricular assist device implantation: Longitudinal changes and relation to aortic valve insufficiency. J Heart Lung Transplant. 2016 Apr; 35: (4)423-32.
    View PubMed
  92. Park KH, Kwon TG, Matsuzawa Y, Sun T, Liu Z, Lennon RJ, Lerman LO, Kushwaha SS, Lerman A. Association between the vasa vasorum and the atherosclerotic changes in cardiac allograft vasculopathy: volumetric analysis. Eur Heart J Cardiovasc Imaging. 2016 Mar; 17 (3):272-9 Epub 2015 Dec 12
    View PubMed
  93. Maltais S, Womack S, Davis ME, Danter MR, Kushwaha SS, Stulak JM, Haglund N. Surgical Considerations and Challenges for Bilateral Continuous-Flow Durable Device Implantation. ASAIO J. 2016 Mar-Apr; 62 (2):e18-21
    View PubMed
  94. Rosenbaum AN, Kremers WK, Schirger JA, Thomas RJ, Squires RW, Allison TG, Daly RC, Kushwaha SS, Edwards BS. Association Between Early Cardiac Rehabilitation and Long-term Survival in Cardiac Transplant Recipients. Mayo Clin Proc. 2016 Feb; 91 (2):149-56
    View PubMed
  95. Singh M, Jensen MD, Lerman A, Kushwaha S, Rihal CS, Gersh BJ, Behfar A, Tchkonia T, Thomas RJ, Lennon RJ, Keenan LR, Moore AG, Kirkland JL. Effect of Low-Dose Rapamycin on Senescence Markers and Physical Functioning in Older Adults with Coronary Artery Disease: Results of a Pilot Study. J Frailty Aging. 2016; 5 (4):204-207
    View PubMed
  96. Snipelisky D, Stulak JM, Schettle SD, Sharma S, Kushwaha SS, Dunlay SM. Psychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapy. Am Heart J. 2015 Nov; 170 (5):887-94 Epub 2015 Aug 16
    View PubMed
  97. Dunlay SM, Haas LR, Herrin J, Schilz SR, Stulak JM, Kushwaha SS, Shah ND. Use of Post-acute Care Services and Readmissions After Left Ventricular Assist Device Implantation in Privately Insured Patients. J Card Fail. 2015 Oct; 21 (10):816-23 Epub 2015 June 18
    View PubMed
  98. Grupper A, Park SJ, Pereira NL, Schettle SD, Gerber Y, Topilsky Y, Edwards BS, Daly RC, Stulak JM, Joyce LD, Kushwaha SS. Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease. J Heart Lung Transplant. 2015 Aug; 34 (8):1042-9 Epub 2015 Mar 26
    View PubMed
  99. Aoki T, Rodriguez-Porcel M, Matsuo Y, Cassar A, Kwon TG, Franchi F, Gulati R, Kushwaha SS, Lennon RJ, Lerman LO, Ritman EL, Lerman A. Evaluation of coronary adventitial vasa vasorum using 3D optical coherence tomography--animal and human studies. Atherosclerosis. 2015 Mar; 239 (1):203-8 Epub 2015 Jan 20
    View PubMed
  100. Guddeti RR, Matsuo Y, Matsuzawa Y, Aoki T, Lerman LO, Kushwaha SS, Lerman A. Clinical implications of intracoronary imaging in cardiac allograft vasculopathy. Circ Cardiovasc Imaging. 2015 Jan; 8: (1).
    View PubMed
  101. Hasin T, Matsuzawa Y, Guddeti RR, Aoki T, Kwon TG, Schettle S, Lennon RJ, Chokka RG, Lerman A, Kushwaha SS. Attenuation in peripheral endothelial function after continuous flow left ventricular assist device therapy is associated with cardiovascular adverse events. Circ J. 2015; 79: (4)770-7.
    View PubMed
  102. Saxena P, Joyce LD, Daly RC, Kushwaha SS, Schirger JA, Rosedahl J, Dearani JA, Kara T, Edwards BS. Cardiac transplantation for radiation-induced cardiomyopathy: the Mayo Clinic experience. Ann Thorac Surg. 2014 Dec; 98(6):2115-21. Epub 2014 Oct 22.
    View PubMed
  103. Hasin T, Kushwaha SS, Lesnick TG, Kremers W, Boilson BA, Schirger JA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Jaffe AS. Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failure. Am J Cardiol. 2014 Oct 15; 114 (8):1257-63 Epub 2014 Aug 01
    View PubMed
  104. Alsara O, Reeves RK, Pyfferoen MD, Trenary TL, Engen DJ, Vitse ML, Kessler SM, Kushwaha SS, Clavell AL, Thomas RJ, Lopez-Jimenez F, Park SJ, Perez-Terzic CM. Inpatient rehabilitation outcomes for patients receiving left ventricular assist device. Am J Phys Med Rehabil. 2014 Oct; 93: (10)860-8.
    View PubMed
  105. Hasin T, Huebner M, Li Z, Brown D, Stulak JM, Boilson BA, Joyce L, Pereira NL, Kushwaha SS, Park SJ. Association of HeartMate II left ventricular assist device flow estimate with thermodilution cardiac output. ASAIO J. 2014 Sep-Oct; 60(5):513-8.
    View PubMed
  106. Guddeti RR, Matsuo Y, Matsuzawa Y, Aoki T, Lennon RJ, Lerman LO, Kushwaha SS, Lerman A. Ischemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantation. J Am Heart Assoc. 2014 Aug 5; 3 (4) Epub 2014 Aug 05
    View PubMed
  107. Fine NM, Daly RC, Shankar N, Park SJ, Kushwaha SS, Gandhi MJ, Pereira NL. The role of donor-specific antibodies in acute cardiac allograft dysfunction in the absence of cellular rejection. Transplantation. 2014 Jul 27; 98 (2):229-38
    View PubMed
  108. Witt CM, Fenstad ER, Cha YM, Kane GC, Kushwaha SS, Hodge DO, Asirvatham SJ, Oh JK, Packer DL, Powell BD. Increase in pulmonary arterial pressure after atrial fibrillation ablation: incidence and associated findings. J Interv Card Electrophysiol. 2014 Jun; 40 (1):47-52 Epub 2014 Feb 16
    View PubMed
  109. Jorde UP, Kushwaha SS, Tatooles AJ, Naka Y, Bhat G, Long JW, Horstmanshof DA, Kormos RL, Teuteberg JJ, Slaughter MS, Birks EJ, Farrar DJ, Park SJ, HeartMate II Clinical Investigators. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2014 May 6; 63 (17):1751-7 Epub 2014 Mar 05
    View PubMed
  110. Dunlay SM, Pereira NL, Kushwaha SS. Contemporary strategies in the diagnosis and management of heart failure. Mayo Clin Proc. 2014 May; 89 (5):662-76 Epub 2014 Mar 29
    View PubMed
  111. Dunlay SM, Park SJ, Joyce LD, Daly RC, Stulak JM, McNallan SM, Roger VL, Kushwaha SS. Frailty and outcomes after implantation of left ventricular assist device as destination therapy. J Heart Lung Transplant. 2014 Apr; 33 (4):359-65 Epub 2013 Dec 27
    View PubMed
  112. Fine NM, Gopalan RS, Arabia FA, Kushwaha SS, Chandrasekaran K. Intraoperative transesophageal echocardiographic guidance of total artificial heart implantation. J Heart Lung Transplant. 2014 Apr; 33: (4)454-7.
    View PubMed
  113. Rosenbaum A, Zhuang K, Kremers W, Allison T, Daly R, Schirger J, Kushwaha S, Edwards B. The positive impact of early cardiac rehabilitation on long term survival in cardiac transplant recipients. J Heart Lung Transplant. 2014 Apr; 33(4):S277-8.
  114. Deo SV, Sung K, Daly RC, Shah IK, Altarabsheh SE, Stulak JM, Joyce LD, Boilson BA, Kushwaha SS, Park SJ. Cardiac transplantation after bridged therapy with continuous flow left ventricular assist devices. Heart Lung Circ. 2014 Mar; 23(3):224-8. Epub 2013 Aug 13.
    View PubMed
  115. Hasin T, Deo S, Maleszewski JJ, Topilsky Y, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Kushwaha SS, Park SJ. The role of medical management for acute intravascular hemolysis in patients supported on axial flow LVAD. ASAIO J. 2014 Jan-Feb; 60(1):9-14.
    View PubMed
  116. Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, Marwick T, Pinney S, Bellazzi R, Favalli V, Kramer C, Roberts R, Zoghbi WA, Bonow R, Tavazzi L, Fuster V, Narula J. The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol. 2013 Dec 3; 62(22):2046-72. Epub 2013 Nov 18.
    View PubMed
  117. Liang JJ, Geske JR, Boilson BA, Frantz RP, Edwards BS, Kushwaha SS, Kremers WK, Weinshilboum RM, Pereira NL. TPMT genetic variants are associated with increased rejection with azathioprine use in heart transplantation. Pharmacogenet Genomics. 2013 Dec; 23 (12):658-65
    View PubMed
  118. Loar RW, Driscoll DJ, Kushwaha SS, Cramer CH, O'Leary PW, Daly RC, Mauriello DA, Johnson JN. Empiric switch from calcineurin inhibitor to sirolimus-based immunosuppression in pediatric heart transplantation recipients. Pediatr Transplant. 2013 Dec; 17 (8):794-9 Epub 2013 Oct 06
    View PubMed
  119. Arbustini E, Narula N, Dec GW, Reddy KS, Greenberg B, Kushwaha S, Marwick T, Pinney S, Bellazzi R, Favalli V, Kramer C, Roberts R, Zoghbi WA, Bonow R, Tavazzi L, Fuster V, Narula J. The MOGE(S) Classification for a Phenotype-Genotype Nomenclature of Cardiomyopathy: Endorsed by the World Heart Federation. Glob Heart. 2013 Dec; 8(4):355-82.
    View PubMed
  120. Fine NM, Topilsky Y, Oh JK, Hasin T, Kushwaha SS, Daly RC, Joyce LD, Stulak JM, Pereira NL, Boilson BA, Clavell AL, Edwards BS, Park SJ. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis. JACC Cardiovasc Imaging. 2013 Nov; 6: (11)1129-40.
    View PubMed
  121. Matsuo Y, Cassar A, Li J, Flammer AJ, Choi BJ, Herrmann J, Gulati R, Lennon RJ, Kang SJ, Maehara A, Kitabata H, Akasaka T, Lerman LO, Kushwaha SS, Lerman A. Repeated episodes of thrombosis as a potential mechanism of plaque progression in cardiac allograft vasculopathy. Eur Heart J. 2013 Oct; 34 (37):2905-15 Epub 2013 June 19
    View PubMed
  122. Hasin T, Gerber Y, McNallan SM, Weston SA, Kushwaha SS, Nelson TJ, Cerhan JR, Roger VL. Patients with heart failure have an increased risk of incident cancer. J Am Coll Cardiol. 2013 Sep 3; 62 (10):881-6 Epub 2013 June 27
    View PubMed
  123. Cassar A, Matsuo Y, Herrmann J, Li J, Lennon RJ, Gulati R, Lerman LO, Kushwaha SS, Lerman A. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography. Eur Heart J. 2013 Sep; 34 (33):2610-7 Epub 2013 June 25
    View PubMed
  124. Shankar N, Daly R, Geske J, Kushwaha SK, Timmons M, Joyce L, Stulak J, Gandhi M, Kremers W, Park S, Pereira NL. LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay. Transplantation. 2013 Aug 15; 96(3):324-30.
    View PubMed
  125. Matsuo Y, Cassar A, Yoshino S, Flammer AJ, Li J, Gulati R, Topilsky Y, Raichlin E, Lennon RJ, Lerman LO, Rihal CS, Kushwaha SS, Lerman A. Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation. J Heart Lung Transplant. 2013 Aug; 32 (8):784-91
    View PubMed
  126. Noheria A, Patel SM, Mirzoyev S, Madhavan M, Friedman PA, Packer DL, Daly RC, Kushwaha SS, Edwards BS, Asirvatham SJ. Decreased postoperative atrial fibrillation following cardiac transplantation: the significance of autonomic denervation. Pacing Clin Electrophysiol. 2013 Jun; 36(6):741-7. Epub 2013 Feb 25.
    View PubMed
  127. Swiecicki PL, Edwards BS, Kushwaha SS, Dispenzieri A, Park SJ, Gertz MA. Left ventricular device implantation for advanced cardiac amyloidosis. J Heart Lung Transplant. 2013 May; 32(5):563-8. Epub 2013 Mar 06.
    View PubMed
  128. Misiri J, DeSimone CV, Park SJ, Kushwaha SS, Friedman PA, Bruce CJ, Asirvatham SJ. Novel nonsurgical left ventricular assist device and system. Cardiovasc Revasc Med. 2013 May-Jun; 14: (3)154-6.
    View PubMed
  129. Topilsky Y, Raichlin E, Hasin T, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Gandhi MJ, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation. Transplantation. 2013 Mar 27; 95(6):859-65.
    View PubMed
  130. Topilsky Y, Gandhi MJ, Hasin T, Voit LL, Raichlin E, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Kushwaha SS, Lerman A, Pereira NL. Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study. Transplantation. 2013 Jan 27; 95 (2):389-96
    View PubMed
  131. Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013 Jan 15; 61 (2):153-63 Epub 2012 Dec 05
    View PubMed
  132. Bishu K, Ogut O, Kushwaha S, Mohammed SF, Ohtani T, Xu X, Brozovich FV, Redfield MM. Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade. PLoS One. 2013; 8 (12):e81325 Epub 2013 Dec 03
    View PubMed
  133. Hardegree EL, Sachdev A, Villarraga HR, Frantz RP, McGoon MD, Kushwaha SS, Hsiao JF, McCully RB, Oh JK, Pellikka PA, Kane GC. Role of serial quantitative assessment of right ventricular function by strain in pulmonary arterial hypertension. Am J Cardiol. 2013 Jan 1; 111(1):143-8. Epub 2012 Oct 23.
    View PubMed
  134. Hasin T, Topilsky Y, Kremers WK, Boilson BA, Schirger JA, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Joyce L, Daly R, Stulak JM, Kushwaha SS, Park SJ, Pereira NL. Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival. Am J Cardiol. 2012 Nov 1; 110 (9):1322-8 Epub 2012 July 21
    View PubMed
  135. Zuckermann A, Keogh A, Crespo-Leiro MG, Mancini D, Vilchez FG, Almenar L, Brozena S, Eisen H, Tai SS, Kushwaha S. Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency. Am J Transplant. 2012 Sep; 12(9):2487-97. Epub 2012 Jul 09.
    View PubMed
  136. Topilsky Y, Hasin T, Raichlin E, Boilson BA, Schirger JA, Pereira NL, Edwards BS, Clavell AL, Rodeheffer RJ, Frantz RP, Maltais S, Park SJ, Daly RC, Lerman A, Kushwaha SS. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 2012 Feb 07; 125: (5)708-20.
    View PubMed
  137. Kushwaha S, Xu X. Target of rapamycin (TOR)-based therapy for cardiomyopathy: evidence from zebrafish and human studies. Trends Cardiovasc Med. 2012 Feb; 22 (2):39-43 Epub 2012 July 28
    View PubMed
  138. Hasin T, Topilsky Y, Schirger JA, Li Z, Zhao Y, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Joyce L, Daly R, Park SJ, Kushwaha SS. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012 Jan 3; 59 (1):26-36
    View PubMed
  139. Park SJ, Kushwaha SS, McGregor CG. State-of-the-art implantable cardiac assist device therapy for heart failure: bridge to transplant and destination therapy. Clin Pharmacol Ther. 2012 Jan; 91(1):94-100. Epub 2011 Nov 23.
    View PubMed
  140. Hasin T, Kushwaha S. Reply. J Am Coll Cardiol. 2012; 59(24):2220.
    View PubMed
  141. Gandhi MJ, DeGoey SR, Bundy K, Kremers WK, Knauer R, Pereira N, Edwards B, Kushwaha S, Daly RC. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes. Transplant Proc. 2011 Dec; 43(10):3840-6.
    View PubMed
  142. Topilsky Y, Hasin T, Oh JK, Borgeson DD, Boilson BA, Schirger JA, Clavell AL, Frantz RP, Tsutsui R, Liu M, Maltais S, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome. Circ Cardiovasc Imaging. 2011 Nov; 4 (6):648-61 Epub 2011 Sept 21
    View PubMed
  143. Raichlin E, Al-Omari MA, Hayes CL, Edwards BS, Frantz RP, Boilson BA, Clavell AL, Rodeheffer RJ, Schirger JA, Kushwaha SS, Allison TG, Pereira NL. Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation. J Heart Lung Transplant. 2011 Oct; 30(10):1153-60. Epub 2011 May 31.
    View PubMed
  144. Ding Y, Sun X, Huang W, Hoage T, Redfield M, Kushwaha S, Sivasubbu S, Lin X, Ekker S, Xu X. Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish. Circ Res. 2011 Sep 2; 109 (6):658-69 Epub 2011 July 14
    View PubMed
  145. Raichlin E, Kushwaha SS, Daly RC, Kremers WK, Frantz RP, Clavell AL, Rodeheffer RJ, Larson TS, Stegall MD, McGregor C, Pereira NL, Edwards BS. Combined heart and kidney transplantation provides an excellent survival and decreases risk of cardiac cellular rejection and coronary allograft vasculopathy. Transplant Proc. 2011 Jun; 43(5):1871-6.
    View PubMed
  146. Khalpey Z, Miller DV, Schmitto JD, Kushwaha SS. Long-term maintenance therapy for post-cardiac transplant monoclonal lymphoproliferative disorder: caveat mammalian target of rapamycin. Transplant Proc. 2011 Jun; 43(5):1893-9.
    View PubMed
  147. Friedman PA, Kushwaha SS, Bruce CJ, Park SJ, Ladewig DJ, Mikell SB, Johnson SB, Suddendorf SH, Danielsen AJ, Asirvatham SJ. Use of the aortoatrial continuity as means of providing left ventricular assist support without entering the ventricle: a feasibility study. J Card Fail. 2011 Jun; 17: (6)511-8.
    View PubMed
  148. Saleh HK, Villarraga HR, Kane GC, Pereira NL, Raichlin E, Yu Y, Koshino Y, Kushwaha SS, Miller FA Jr, Oh JK, Pellikka PA. Normal left ventricular mechanical function and synchrony values by speckle-tracking echocardiography in the transplanted heart with normal ejection fraction. J Heart Lung Transplant. 2011 Jun; 30 (6):652-8 Epub 2010 Dec 30
    View PubMed
  149. Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS, Joyce LD, Park SJ. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail. 2011 May; 4(3):266-75. Epub 2011 Feb 08.
    View PubMed
  150. Gharacholou SM, Maleszewski JJ, Borlaug BA, Cosio FG, Dearani JA, Kushwaha SS, Ammash NM. "Carcinoid-like" tricuspid valvulopathy associated with nephrogenic systemic fibrosis. Echocardiography. 2011 Mar; 28: (3)E46-9.
    View PubMed
  151. Topilsky Y, Oh JK, Shah DK, Boilson BA, Schirger JA, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC Cardiovasc Imaging. 2011 Mar; 4: (3)211-22.
    View PubMed
  152. Topilsky Y, Oh JK, Atchison FW, Shah DK, Bichara VM, Schirger JA, Kushwaha SS, Pereira NL, Park SJ. Echocardiographic findings in stable outpatients with properly functioning HeartMate II left ventricular assist devices. J Am Soc Echocardiogr. 2011 Feb; 24: (2)157-69.
    View PubMed
  153. Pereira NL, Chen D, Kushwaha SS, Park SJ. Discontinuation of antithrombotic therapy for a year or more in patients with continuous-flow left ventricular assist devices. Interact Cardiovasc Thorac Surg. 2010 Oct; 11 (4):503-5 Epub 2010 July 16
    View PubMed
  154. Pereira NL, Park SJ, Daly RC, Kushwaha SS, Edwards WD. De novo development of eosinophilic myocarditis with left ventricular assist device support as bridge to transplant. Ann Thorac Surg. 2010 Oct; 90 (4):1345-7
    View PubMed
  155. Boilson BA, Raichlin E, Park SJ, Kushwaha SS. Device therapy and cardiac transplantation for end-stage heart failure. Curr Probl Cardiol. 2010 Jan; 35(1):8-64.
    View PubMed
  156. Raichlin E, Daly RC, Rosen CB, McGregor CG, Charlton MR, Frantz RP, Clavell AL, Rodeheffer RJ, Pereira NL, Kremers WK, Kushwaha SS, Edwards BS. Combined heart and liver transplantation: a single-center experience. Transplantation. 2009 Jul 27; 88 (2):219-25
    View PubMed
  157. Raichlin E, Prasad A, Kremers WK, Edwards BS, Rihal CS, Lerman A, Kushwaha SS. Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients. Eur Heart J. 2009 Jun; 30(11):1356-63. Epub 2009 Apr 21.
    View PubMed
  158. Raichlin E, Kushwaha SS, Lennon RJ, Frantz RP, Edwards BS, Prasad A, Rihal CS, Lerman A. Features of cardiac allograft coronary endothelial dysfunction. Am J Cardiol. 2009 Apr 15; 103: (8)1154-8.
    View PubMed
  159. Raichlin E, Bae JH, Kushwaha SS, Lennon RJ, Prasad A, Rihal CS, Lerman A. Inflammatory burden of cardiac allograft coronary atherosclerotic plaque is associated with early recurrent cellular rejection and predicts a higher risk of vasculopathy progression. J Am Coll Cardiol. 2009 Apr 14; 53: (15)1279-86.
    View PubMed
  160. Raichlin E, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Pereira NL, Daly RC, McGregor CG, Lerman A, Kushwaha SS. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation. J Heart Lung Transplant. 2009 Apr; 28(4):320-7.
    View PubMed
  161. van de Beek D, Kremers WK, Kushwaha SS, McGregor CG, Wijdicks EF. No major neurologic complications with sirolimus use in heart transplant recipients. Mayo Clin Proc. 2009 Apr; 84 (4):330-2
    View PubMed
  162. Raichlin E, Villarraga HR, Chandrasekaran K, Clavell AL, Frantz RP, Kushwaha SS, Rodeheffer RJ, McGregor CG, Daly RC, Park SJ, Kremers WK, Edwards BS, Pereira NL. Cardiac allograft remodeling after heart transplantation is associated with increased graft vasculopathy and mortality. Am J Transplant. 2009 Jan; 9 (1):132-9 Epub 2008 Nov 27
    View PubMed
  163. Raichlin E, Chandrasekaran K, Kremers WK, Frantz RP, Clavell AL, Pereira NL, Rodeheffer RJ, Daly RC, McGregor CG, Edwards BS, Kushwaha SS. Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft. Transplantation. 2008 Nov 27; 86: (10)1395-400.
    View PubMed
  164. Kushwaha SS, Raichlin E, Sheinin Y, Kremers WK, Chandrasekaran K, Brunn GJ, Platt JL. Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients. Eur Heart J. 2008 Nov; 29 (22):2742-50 Epub 2008 Sept 11
    View PubMed
  165. Raichlin E, Kushwaha SS. Proliferation signal inhibitors and cardiac allograft vasculopathy. Curr Opin Organ Transplant. 2008 Oct; 13(5):543-50.
    View PubMed
  166. Lacy MQ, Dispenzieri A, Hayman SR, Kumar S, Kyle RA, Rajkumar SV, Edwards BS, Rodeheffer RJ, Frantz RP, Kushwaha SS, Clavell AL, Dearani JA, Sundt TM, Daly RC, McGregor CG, Gastineau DA, Litzow MR, Gertz MA. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy. J Heart Lung Transplant. 2008 Aug; 27 (8):823-9 Epub 2008 July 03
    View PubMed
  167. Khalpey Z, Kushwaha SS. 'Rapping' up cardiac allograft vasculopathy. Clin Cardiol. 2008 Jun; 31 (6):286-7
    View PubMed
  168. Raichlin E, Bae JH, Khalpey Z, Edwards BS, Kremers WK, Clavell AL, Rodeheffer RJ, Frantz RP, Rihal C, Lerman A, Kushwaha SS. Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation. 2007 Dec 04; 116: (23)2726-33.
    View PubMed
  169. Raichlin E, Khalpey Z, Kremers W, Frantz RP, Rodeheffer RJ, Clavell AL, Edwards BS, Kushwaha SS. Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients. Transplantation. 2007 Aug 27; 84(4):467-74.
    View PubMed
  170. Raichlin ER, McConnell JP, Lerman A, Kremers WK, Edwards BS, Kushwaha SS, Clavell AL, Rodeheffer RJ, Frantz RP. Systemic inflammation and metabolic syndrome in cardiac allograft vasculopathy. J Heart Lung Transplant. 2007 Aug; 26 (8):826-33
    View PubMed
  171. Puri A, McGoon MD, Kushwaha SS. Pulmonary arterial hypertension: current therapeutic strategies. Nat Clin Pract Cardiovasc Med. 2007 Jun; 4(6):319-29.
    View PubMed
  172. Bae JH, Rihal CS, Edwards BS, Kushwaha SS, Mathew V, Prasad A, Holmes DR, Lerman A. Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy. Transplantation. 2006 Oct 27; 82(8):1108-11.
    View PubMed
  173. Ahmari SA, Bunch TJ, Chandra A, Chandra V, Ujino K, Daly RC, Kushwaha SS, Edwards BS, Maalouf YF, Seward JB, McGregor CG, Chandrasekaran K. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. J Heart Lung Transplant. 2006 Jan; 25(1):53-60. Epub 2005 Nov 02.
    View PubMed
  174. Miller WL, Edwards BS, Kremers WK, Kushwaha SS, McGregor CGA, Daly RC, Jaffe AS. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy. J Heart Lung Transplant. 2005 Dec; 24(12):2075-8.
  175. Kushwaha SS, Khalpey Z, Frantz RP, Rodeheffer RJ, Clavell AL, Daly RC, McGregor CG, Edwards BS. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant. 2005 Dec; 24 (12):2129-36
    View PubMed
  176. Kushwaha SS. Cardiac structure and function. J Am Coll Cardiol. 2004 Jul 21; 44(2 Suppl S):2A-6A.
    View PubMed
  177. Simper D, Wang S, Deb A, Holmes D, McGregor C, Frantz R, Kushwaha SS, Caplice NM. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation. 2003 Jul 15; 108 (2):143-9 Epub 2003 June 30
    View PubMed
  178. Mayer DF, Kushwaha SS. Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases. Curr Opin Rheumatol. 2003 May; 15 (3):219-25
    View PubMed
  179. Squires RW, Leung TC, Cyr NS, Allison TG, Johnson BD, Ballman KV, Wagner JA, Olson LJ, Frantz RP, Edwards BS, Kushwaha SS, Dearani JA, Daly RC, McGregor CG, Rodeheffer RJ. Partial normalization of the heart rate response to exercise after cardiac transplantation: frequency and relationship to exercise capacity. Mayo Clin Proc. 2002 Dec; 77(12):1295-300.
    View PubMed
  180. Krishnan SC, Falsone JM, Sanders WE, Chen H, Mill MR, Kushwaha SS. Catheter ablation of atrial flutter in a heart transplant recipient. Pacing Clin Electrophysiol. 2002 Aug; 25(8):1262-5.
    View PubMed
  181. Baran DA, Segura L, Kushwaha S, Courtney M, Correa R, Fallon JT, Cheng J, Lansman SL, Gass AL. Tacrolimus monotherapy in adult cardiac transplant recipients: intermediate-term results. J Heart Lung Transplant. 2001 Jan; 20(1):59-70.
    View PubMed
  182. Kushwaha SS, Ambrose JA. Does ischemic preconditioning limit infarct size in non-Q-wave myocardial infarction? Coron Artery Dis. 2000 Mar; 11(2):191-4.
    View PubMed
  183. Alexis JD, Nayak HM, Kushwaha SS, Lansman SL, Mehta D, Gass AL. New preexcitation following cardiac transplant. Int J Cardiol. 1998 Jun 1; 65(1):71-4.
    View PubMed
  184. Alexis JD, Lao CD, Selter JG, Courtney MC, Correa DK, Lansman SL, Kushwaha SS, Gass AL. Cardiac troponin T: a noninvasive marker for heart transplant rejection? J Heart Lung Transplant. 1998 Apr; 17(4):395-8.
    View PubMed
  185. Kushwaha SS, Narula J, Narula X, Zervos G, Semigran S, Fischman A, Alpert N, Dec GW, Gewirtz H. Natural history of changes in myocardial blood flow and microvascular dilator capacity in humans following orthotopic cardiac transplantation: observations in patients with normally functioning allografts. Am J Cardiol. 1998; 82:1377-81.
    View PubMed
  186. Rechavia E, de Silva R, Kushwaha SS, Rhodes CG, Araujo LI, Jones T, Maseri A, Yacoub MH. Enhanced myocardial 18F-2-fluoro-2-deoxyglucose uptake after orthotopic heart transplantation assessed by positron emission tomography. J Am Coll Cardiol. 1997 Aug; 30(2):533-8.
    View PubMed
  187. Kushwaha SS, Fallon JT, Fuster V. Medical Progress: Restrictive Cardiomyopathy. N Engl J Med. 1997; 336:267-76.
    View PubMed
  188. Kushwaha SS, Bustami M, Tadjkarimi S, Ilsley CD, Mitchell AG, Yacoub MH. Late endothelial function of free and pedicled internal mammary artery grafts. J Thorac Cardiovasc Surg. 1995 Aug; 110(2):453-62.
    View PubMed
  189. Kushwaha SS, Bustami M, Lythall DA, Barbir M, Mitchell AG, Yacoub MH. Coronary endothelial function in cardiac transplant recipients with accelerated coronary disease. Coron Artery Dis. 1994 Feb; 5(2):147-54.
    View PubMed
  190. Kushwaha S, Banner N, Patel N, Cox A, Patton H, Yacoub M. The effect of beta blockade on the cardiopulmonary and neurohumoral response to dynamic exercise in cardiac transplant recipients. Br Heart J. 1994; 71:431-6.
    View PubMed
  191. Kushwaha S, Fuster V. The need for coronary surgery. Annual of Cardiac Surgery pp 95-13 Current Science London. 1994.
  192. Kushwaha S, Fuster V. The need for coronary surgery in 1993. Current Opinion in Cardiology. 1993; 8:889-96.
    View PubMed
  193. Lythall DA, Gibson DG, Kushwaha SS, Norell MS, Mitchell AG, Ilsley CJ. Changes in myocardial echo amplitude during reversible ischaemia in humans. Br Heart J. 1992 May; 67(5):368-76.
    View PubMed
  194. Norell M, Lythall D, Coghlan G, Cheng A, Kushwaha S, Swan J, Ilsley C, Mitchell A. Limited value of the resting electrocardiogram in assessing patients with recent onset chest pain: lessons from a chest pain clinic. Br Heart J. 1992; 67:53-6.
    View PubMed
  195. Kushwaha SS, Steinberg VL. Cauda equina syndrome in ankylosing spondylitis in a female. Postgrad Med J. 1992; 68:485-6.
    View PubMed
  196. Barbir M, Kushwaha S, Hunt B, Macken A, Thompson GR, Mitchell A, Robinson D, Yacoub M. Lipoprotein (a) and accelerated coronary artery disease in cardiac transplant recipients. Lancet. 1992; 340:1500-2.
    View PubMed
  197. Barbir M, Hunt B, Kushwaha S, Kehely A, Prescot R, Thompson GR, Mitchell A, Yacoub M. Maxepa versus Bezafibrate in hyperlipidemic cardiac transplant recipients. Am J Cardiol. 1992; 70:1596-601.
    View PubMed
  198. Rechavia E, Araujo LI, De Silva R, Kushwaha SS, Lammertsma AA, Jones T, Mitchell A, Maseri A, Yacoub MH. Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol. 1992 Jan; 19(1):100-6.
    View PubMed
  199. Lythall DA, Logan-Sinclair RB, Ilsley CJ, Kushwaha SS, Yacoub MH, Gibson DG. Relation between cyclic variation in echo amplitude and segmental contraction in normal and abnormal hearts. Br Heart J. 1991 Oct; 66(4):268-76.
    View PubMed
  200. Kushwaha SS, Crossman DC, Bustami M, Davies GJ, Mitchell AG, Maseri A, Yacoub MH. Substance P for evaluation of coronary endothelial function after cardiac transplantation. J Am Coll Cardiol. 1991 Jun; 17(7):1537-44.
    View PubMed
  201. Kushwaha SS, Lythall DL, Maseri A, Mitchell AG, Yacoub MH. Coronary reactivity to ergonovine - possible relationship to accelerated coronary arterial disease in cardiac transplant recipients. European Heart Journal. 1991; 12:520-5.
    View PubMed
  202. O'Neil GS, Chester AH, Kushwaha S, Rose M, Tadijkarimi S, Yacoub M. Cyclosporin treatment does not impair the release of nitric oxide in human coronary arteries. Br Heart J. 1991; 66:212-6.
    View PubMed
  203. Barbir M, Rose M, Kushwaha S, Akl S, Mitchell A, Yacoub M. Low-dose simvastatin for the treatment of hypercholesterolemia in recipients of cardiac transplantation. Int J Cardiol. 1991; 33:241-6.
    View PubMed
  204. Akasaka T, Lythall DA, Kushwaha SS, Yoshida K, Yoshikawa J, Yacoub MH. Valvular regurgitation in heart-lung transplant recipients: a Doppler color flow study. J Am Coll Cardiol 1. 1990 Mar; 15: (3)576-81.
  205. Kushwaha SS, Jepson EM. Resolution of right atrial thrombus following anticoagulation. Int J Cardiol. 1990; 27:269-71.
    View PubMed
  206. Kushwaha SS, Mitchell AG, Yacoub MH. Coronary artery spasm after cardiac transplantation. AM J Cardiol. 1990; 65:1515-8.
    View PubMed
  207. Kibbler CC, Cohen DL, Cruicshank JK, Kushwaha SS, Morgan MY, Dick RD. Use of CAT scanning in the diagnosis and management of hepatic artery aneurysm. Gut. 1985 Jul; 26(7):752-6.
    View PubMed